Clinical Trial Update: Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating ruxolitinib in combination with CHOP chemotherapy as first-line therapy for untreated nodal Follicular Helper T-cell Lymphomas, includi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioimmunoblastic T-cell Lymphoma
• Follicular Helper T-cell Lymphoma
• Mature T-cell and Nk-cell Non-hodgkin Lymphoma
• Peripheral T-cell Lymphoma Not Otherwise Specified

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Ruxolitinib (ruxolitinib)
• Vincristine (vincristine)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Follicular Helper T-Cell Lymphoma, Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type | Phase 1 | Status: NOT_YET_RECRUITING